Radiosurgery Dose Distributions: Theoretical Impact of Inhomogeneities on Lesion Control

  • Lawrence B. Marks
Part of the Acta Neurochirurgica Supplementum book series (NEUROCHIRURGICA, volume 62)

Summary

Objective: To develop a mathematical model to predict the impact of dose heterogeneities on tumor/lesion control during radiosurgery. It is necessary to be able to estimate these effects in order to quantitatively and objectively assess competing treatment plans.

Methods: Target cells are assumed to be uniformly distributed throughout the lesion. The control rate for the entire lesion is assumed to be the product of the control probabilities for each subregion within the target volume. The lesion control probability (LCP) for each region is assumed to equal EXP (the number of surviving target cells within the subregion), as predicted by Poisson statistics. Subregions of variable size are assumed to receive variable doses, and the impact of this dose heterogeneity on the LCP is calculated based on the single-fraction radiation cell survival curve predicted by the single-hit multitarget model.

Results: The impact of a dose heterogeneity on LCP is related to three variables: the LCP predicted with uniform irradiation, the volume of the lesion that is irradiated to a new dose, and the magnitude of the dose change relative to the slope of the single- fraction radiation cell survival curve of (ΔD/D0). The calculations predict that the detrimental effect of underdosing regions of the lesion can, in some instances, be offset by escalating the dose to other subregions within the target volume. In this regard, the “average” dose delivered to the lesion rather than the minimum dose may be most predictive of the lesion control probability. In some situations, escalating the dose to part of the lesion may improve the lesion control rate.

Conclusion: These calculations quantify the theoretical impact of dose heterogeneities on lesion control rate and may be very useful when comparing competing treatment plans.

Keywords

Radiosurgery treatment planning dose heterogeneity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fletcher GH (1980) Textbook of radiotherapy, 3rd Ed. Lea and Febiger, PhiladelphiaGoogle Scholar
  2. 2.
    Koutcher JA, Okunieff P. Neuringer L, Suit H, Phil D, Brady T (1987) Size dependent changes in tumor phosphate metabolism after radiation therapy as detected by 31P NMR spectroscopy. Int J Radiat Oncol Biol Phys 13: 1851–1855PubMedCrossRefGoogle Scholar
  3. 3.
    Malaise EP, Firtil B, Chavaudra N, Guichard M (1986) Distribution of radiation sensitivities for human tumor cells of specific histologic types: Comparison of in vitro and in vivo data. Int J Radiat Oncol Biol Phys 12: 617–624PubMedCrossRefGoogle Scholar
  4. 4.
    Moulder JE (1984) Hypoxic fractions of solid tumors experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10: 695–712PubMedCrossRefGoogle Scholar
  5. 5.
    Nedzi LA, Kooky H, Alexander E, III, et al (1991) Variables associated with the development of complications from radiosurgery of intracranial tumors. Int J Radiat Oncol Biol Phys 21: 591–599PubMedCrossRefGoogle Scholar
  6. 6.
    Podgorsak EB (1982) Physics for radiosurgery with linear accelerators. Neurosurg Clin N Am 3: 9–34Google Scholar
  7. 7.
    Podgorsak Ev, Pike GB, Olivier A, Pla M, Souhami L (1989) Radiosurgery with high energy photon beams: a comparison among techniques. Int J Radiat Oncol Biol Phys 16: 857–865PubMedCrossRefGoogle Scholar
  8. 8.
    Quiet CA, Weichselbaum RR, Grdina DJ (1991) Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas. Int J Radiat Oncol Biol Phys 20: 733–738PubMedCrossRefGoogle Scholar
  9. 9.
    Rasey JS, Koh WJ, Grierson JR, Grunbaum Z, Krohn KA (1989) Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 17: 985–991PubMedCrossRefGoogle Scholar
  10. 10.
    Steiner L, Leksell L, Greitz T, Forster DMC, Backlund EO (1972) Sterotactic radiosurgery for cerebral arteriovenous mal-formations. Acta Chir Scand 138: 459–464PubMedGoogle Scholar
  11. 11.
    Suit HD, Urano M (1988) Radiation biology for radiation therapy. In: Wang CC (ed) Clinical radiation oncology. PSG, Littleton, pp 17–55Google Scholar
  12. 12.
    Thames HD, Hendry JH (1987) Fraction in radiotherapy. Taylor and Francis, LondonGoogle Scholar
  13. 13.
    Wu A (1982) Physics and dosimetry of the gamma knife. Neurosurg Clin N Am 3: 35–50Google Scholar
  14. 14.
    Yaes RJ (1989) Tumor heterogeneity, tumor size, and radioresis- tance. Int J Radiat Oncol Biol Phys 17: 993–1005PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Lawrence B. Marks
    • 1
  1. 1.Department of Radiation OncologyDuke University Medical CenterDurhamUSA

Personalised recommendations